Evidence map›Paper›PMID 33920126›Full record

ReviewLife (Basel, Switzerland)2021

Theranostics in Boron Neutron Capture Therapy.

Wolfgang A G Sauerwein, Lucie Sancey, Evamarie Hey-Hawkins, Martin Kellert, Luigi Panza, Daniela Imperio, Marcin Balcerzyk, Giovanna Rizzo, Elisa Scalco, Ken Herrmann and 3 more

Abstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Quantification ofMedicinal research reviews · 2026
    Review
  2. Review
  3. Review
  4. Boron in Diet and Medicine: Mechanisms of Delivery and Detection.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Recent Development of Boron-Containing Small-Molecule Anticancer Agents.ACS pharmacology & translational science · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Targeting the organelle for radiosensitization in cancer radiotherapy.Asian journal of pharmaceutical sciences · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wolfgang A G SauerweinDeutsche Gesellschaft für Bor-Neutroneneinfangtherapie DGBNCT e.V., 45122 Essen, Germany.ORCID 0000-0002-5027-5913
Lucie SanceyUGA/Inserm U 1209/CNRS UMR 5309 Joint Research Center, Institute for Advanced Biosciences, 38700 La Tronche, France.ORCID 0000-0002-0084-3775
Evamarie Hey-HawkinsDeutsche Gesellschaft für Bor-Neutroneneinfangtherapie DGBNCT e.V., 45122 Essen, Germany.ORCID 0000-0003-4267-0603
Martin KellertInstitute of Inorganic Chemistry, Department of Chemistry and Mineralogy, University Leipzig, 04109 Leipzig, Germany.ORCID 0000-0003-4334-1836
Luigi PanzaDeutsche Gesellschaft für Bor-Neutroneneinfangtherapie DGBNCT e.V., 45122 Essen, Germany.ORCID 0000-0002-0785-0409
Daniela ImperioDeutsche Gesellschaft für Bor-Neutroneneinfangtherapie DGBNCT e.V., 45122 Essen, Germany.ORCID 0000-0001-6810-1439
Marcin BalcerzykDepartamento de Fisiología Medica y Biofísica, Universidad de Sevilla, 41004 Sevilla, Spain.ORCID 0000-0001-6030-7416
Giovanna RizzoInstitute for Biomedical Technologies (ITB-CNR), 93, 20090 Segrate, Italy.
Elisa ScalcoInstitute for Biomedical Technologies (ITB-CNR), 93, 20090 Segrate, Italy.ORCID 0000-0003-2721-5792
Ken HerrmannDepartment for Nuclear Medicine, University Hospital Essen, 45147 Essen, Germany.ORCID 0000-0002-9662-7259
PierLuigi MauriDeutsche Gesellschaft für Bor-Neutroneneinfangtherapie DGBNCT e.V., 45122 Essen, Germany.ORCID 0000-0003-4364-0393
Antonella De PalmaProteomics and Metabolomics Laboratory, ELIXIR Infrastructure, National Research Council (ITB-CNR), 20090 Segrate, Italy.ORCID 0000-0001-5937-8604
Andrea WittigDeutsche Gesellschaft für Bor-Neutroneneinfangtherapie DGBNCT e.V., 45122 Essen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Boron neutron capture therapy (BNCT) has the potential to specifically destroy tumor cells without damaging the tissues infiltrated by the tumor. BNCT is a binary treatment method based on the combination of two agents that have no effect when applied individually:

Indexed as

BNCTBPABSHcell-penetrating peptides CPPimage registrationPETproteomicsquantitative MRIradiation oncologysmall molecules

Identifiers

PMID33920126
PMCPMC8070338

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.